Puma Biotechnology, Inc. (PBYI)
6.76
+0.37
(+5.79%)
USD |
NASDAQ |
Apr 01, 16:00
6.75
-0.01
(-0.15%)
After-Hours: 20:00
Puma Biotechnology Shareholders Equity (Quarterly) : 130.34M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 391.48M |
| AbbVie, Inc. | -3.27B |
| Trevi Therapeutics, Inc. | 183.24M |
| Phathom Pharmaceuticals, Inc. | -438.17M |
| Terns Pharmaceuticals, Inc. | 1.007B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.67M |
| Total Liabilities (Quarterly) | 87.33M |
| Debt to Equity Ratio | 0.219 |
| Current Ratio | 2.002 |
| Net Debt Paydown Yield | 3.86% |